Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics.
Jönsson G, Staaf J, Vallon-Christersson J, Ringnér M, Holm K, Hegardt C, Gunnarsson H, Fagerholm R, Strand C, Agnarsson BA, Kilpivaara O, Luts L, Heikkilä P, Aittomäki K, Blomqvist C, Loman N, Malmström P, Olsson H, Johannsson OT, Arason A, Nevanlinna H, Barkardottir RB, Borg A. Jönsson G, et al. Among authors: strand c. Breast Cancer Res. 2010;12(3):R42. doi: 10.1186/bcr2596. Epub 2010 Jun 24. Breast Cancer Res. 2010. PMID: 20576095 Free PMC article.
High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer.
Johansson I, Nilsson C, Berglund P, Strand C, Jönsson G, Staaf J, Ringnér M, Nevanlinna H, Barkardottir RB, Borg A, Olsson H, Luts L, Fjällskog ML, Hedenfalk I. Johansson I, et al. Among authors: strand c. Breast Cancer Res Treat. 2011 Oct;129(3):747-60. doi: 10.1007/s10549-010-1262-8. Epub 2010 Nov 27. Breast Cancer Res Treat. 2011. PMID: 21113657
Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence after breast-conservation surgery, with or without postoperative radiotherapy.
Niméus-Malmström E, Krogh M, Malmström P, Strand C, Fredriksson I, Karlsson P, Nordenskjöld B, Stål O, Ostberg G, Peterson C, Fernö M. Niméus-Malmström E, et al. Among authors: strand c. Breast Cancer Res. 2008;10(2):R34. doi: 10.1186/bcr1997. Epub 2008 Apr 22. Breast Cancer Res. 2008. PMID: 18430221 Free PMC article.
Exploring the two-gene ratio in breast cancer--independent roles for HOXB13 and IL17BR in prediction of clinical outcome.
Jerevall PL, Brommesson S, Strand C, Gruvberger-Saal S, Malmström P, Nordenskjöld B, Wingren S, Söderkvist P, Fernö M, Stål O. Jerevall PL, et al. Among authors: strand c. Breast Cancer Res Treat. 2008 Jan;107(2):225-34. doi: 10.1007/s10549-007-9541-8. Epub 2007 Apr 24. Breast Cancer Res Treat. 2008. PMID: 17453342 Clinical Trial.
The prognostic value of mitotic activity index (MAI), phosphohistone H3 (PPH3), cyclin B1, cyclin A, and Ki67, alone and in combinations, in node-negative premenopausal breast cancer.
Klintman M, Strand C, Ahlin C, Beglerbegovic S, Fjällskog ML, Grabau D, Gudlaugsson E, Janssen EA, Lövgren K, Skaland I, Bendahl PO, Malmström P, Baak JP, Fernö M. Klintman M, et al. Among authors: strand c. PLoS One. 2013 Dec 4;8(12):e81902. doi: 10.1371/journal.pone.0081902. eCollection 2013. PLoS One. 2013. PMID: 24324728 Free PMC article.
The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer.
Strand C, Bak M, Borgquist S, Chebil G, Falck AK, Fjällskog ML, Grabau D, Hedenfalk I, Jirström K, Klintman M, Malmström P, Olsson H, Rydén L, Stål O, Bendahl PO, Fernö M. Strand C, et al. Springerplus. 2013 Dec;2(1):111. doi: 10.1186/2193-1801-2-111. Epub 2013 Mar 14. Springerplus. 2013. PMID: 23560250 Free PMC article.
157 results